Alzheimer’s Disease International (2010). World Alzheimer Report 2010, the global economic impact of dementia. Alzheimer’s Disease International.
Alzheimer’s Society (2014). Dementia UK, update, 2nd edn. Alzheimer’s Society.
Beecham, J. and Knapp, M.R. (1992). Costing psychiatric intervention. In: Thornicroft, G., Brewin, C.R. and Wing, J. (Eds.), Measuring Mental Health Needs. London: Gaskell.
Brimblecombe, N., Fernandez, J.L., Knapp, M., Rehill, A. and Wittenberg, R. (2016). Unpaid Care in England, Future Patterns and Potential Support Strategies. Downloaded from http://eprints.lse.ac.uk/90215/1/.
Charlson, M.E. (1987). Studies of prognosis: progress and pitfalls. Journal of General Internal Medicine, 2, 359–361.
Cohen-Mansfield, J., Marx, M.S. and Rosenthal, A.S. (1989). A description of agitation in a nursing home. The Journals of Gerontology, 44, M77–M84.
Curtis, L. (2012). Unit Costs of Health and Social Care 2012. Canterbury: Personal Social Services Research Unit, University of Kent.
Desgagne, A., Castilloux, A.M., Angers, J.F. and LeLorier, J. (1998). The use of the bootstrap statistical method for the pharmacoeconomic cost analysis of skewed data. Pharmacoeconomics, 13, 487–497.
Etkind, S.N.et al. (2017). How many people will need palliative care in 2040? Past trends, future projections and implications for services. BMC Medicine. doi: 10.1186/s12916-017-0860-2.
Garber, A.M., Weinstein, M.C., Torrance, G.W. and Kamlet, M.S. (1996). Theoretical foundations of costeffectiveness analysis. In Gold, M.R., Siegel, J.E., Russel, L.B. and Weinstein, M.C. (Eds.), Cost-Effectiveness in Health and Medicine (pp. 25–53). New York: Oxford University Press.
Grossman, M. (1972). On the concept of health capital and the demand for health. Journal of Political Economy, 80, 223–585.
Handley, M.et al. (2014). Living and dying, responsibility for end-of-life care in care homes without on-site nursing provision – a prospective study. Health & Social Care in the Community, 22, 22–29.
Health Economics Research Centre, University of Oxford for the Alzheimer’s Research Trust (2010) Dementia 2010: The economic burden of dementia and associated research funding in the United Kingdom.
Husebo, B.S., Ballard, C., Sandvik, R., Nilsen, O.B. and Aarsland, D. (2011). Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial. British Medical Journal, 343, d4065.
Jakobson, E., Avari, J. and Kalayam, B. (2015). Non-pharmacologic interventions for treatment of agitation in dementia in nursing home residents. The American Journal of Geriatric Psychiatry, 23, S139–S140.
Jones, L.et al. (2012). CoMPASs: IOn programme (care of memory problems in advanced stages of dementia: improving our knowledge): protocol for a mixed methods study. British Medical Journal Open, 2, e002265.
Jönsson, L.et al. (2006). Determinants of costs of care for patients with Alzheimer’s disease. International Journal of Geriatric Psychiatry, 21, 449–459.
Kiely, D.K., Volicer, L., Teno, J., Jones, R.N., Prigerson, H.G. and Mitchell, S.L. (2006). The validity and reliability of scales for the evaluation of end-of-life care in advanced dementia. Alzheimer Disease and Associated Disorders, 20, 176–181.
Kinley, J.et al. (2014). The provision of care for residents dying in U.K. nursing care homes. Age and Ageing, 43, 375–379. doi: 10.1093/ageing/aft158.
Konig, H.H.et al. (2014). The costs of dementia from the societal perspective, is care provided in the community really cheaper than nursing home care? Journal of the American Medical Directors Association, 15, 117–126.
Leicht, H.et al. (2013). AgeCoDe Study Group, predictors of costs in dementia in a longitudinal perspective. PLoS One, 8, e70018.
Livingston, G., Katona, C., Roche, B., Guilhaume, C. and Rive, B. (2004). A dependency model for patients with Alzheimer’s disease, its validation and relationship to the costs of care – the LASER AD study. Current Medical Research and Opinion, 20, 1007–1016.
Livingston, G.et al. (2017). Prevalence of and associations with agitation in residents with dementia living in care homes, MARQUE cross-sectional study. BMJ Open, 3, 171–178. doi: 10.1192/bjpo.bp.117.005181.
Luengo-Fernandez, R., Leal, J. and Gray, A. (2015). UK research spend in 2008 and 2012, comparing stroke, cancer, coronary heart disease and dementia. BMJ Open, 5, e006648. doi: 10.1136/bmjopen-2014-006648.
Matthews, F.et al. (2013). A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England, results of the Cognitive Function and Ageing Study I and II – on behalf of the Medical Research Council Cognitive Function and Ageing Collaboration. The Lancet, 382, 1405–1412. doi: 10.1016/S0140-6736(13)61570-6.
Moore, K.J.et al. (2017). Experiences of end of life amongst family carers of people with advanced dementia, longitudinal cohort study with mixed methods. BMC Geriatrics, 17, 135.
Morris, S.et al. (2015). Monetary costs of agitation in older adults with Alzheimer’s disease in the UK, prospective cohort study. British Journal of Psychiatry Open, 5, e007382. doi: 10.1136/bmjopen-2014-007382.
Murman, D, High, R, Charlton, M. and Mclaughlin, T. (2009). Predicting costs of care for unique dependence levels in patients with Alzheimer’s disease. Alzheimers & Dementia, 5, P408. doi: 10.1016/j.jalz.2009.04.994.
National Council for Palliative Care (2015). Published July 2015 by the National Council for Palliative Care.
National Institute for Health and Care Excellence (NICE) (2013). Guide to the methods of technology appraisal 2013.
Prince, M.et al. (2014). Demenita UK, Update Second Edition report produced by King’s College London, the London School of Economics for the Alzheimer’s Society.
Prince, M., Wimo, A., Guerchet, M., Ali, G-C., Wu, Y-T. and Prina, M. (2015). World Alzheimer Report 2015. The Global Impact of Dementia. An analysis of prevalence, incidence, costs and trends. London, Alzheimers Diseases International.
Public Health England (2018). Guidance Dementia, applying All Our Health, Updated 23 January 2018.
Ratcliffe, J.et al. (2017). An empirical comparison of the EQ-5D-5L, DEMQOL-U and DEMQOL-Proxy-U in a post-hospitalisation population of frail older people living in residential aged care. Applied Health Economics and Health Policy, 15, 399–412.
Reisberg, B. (1998). Functional assessment staging (FAST). Psychopharmacology Bulletin, 24, 653–659.
Ridder, H.M., Stige, B., Qvale, L.G. and Gold, C. (2013). Individual music therapy for agitation in dementia, an exploratory randomized controlled trial. Aging & Mental Health, 17, 667–678.
Rizzuto, D., Bellocco, R., Kivipelto, M., Clerici, F., Wimo, A. and Fratiglioni, L. (2012). Dementia after age 75, survival in different severity stages and years of life lost. Current Alzheimer Research, 9, 795–800.
Rubin, D.B. (1987). Multiple Imputation for Nonresponse in Surveys. New York: Wiley.
Sampson, E.L.et al. (2017). Living and dying with advanced dementia, a prospective cohort study of symptoms, service use and care at the end of life. Palliative Medicine, 32, 668–681. doi: 10.1177/0269216317726443.
Schwarzkopf, L.et al. (2011). Costs of care for dementia patients in community setting, an analysis for mild and moderate disease stage. Value Health, 14, 827–835.
Seymour, J.E., Kumar, A. and Froggatt, K. (2011). Do nursing homes for older people have the support they need to provide end-of-life care? A mixed methods enquiry in England. Palliative Medicine, 25, 125–38. doi: 10.1177/0269216310387964.
Sleeman, K.E., Ho, Y.K., Verne, J., Gao, W. and Higginson, I.J. (2014). Reversal of English trend towards hospital death in dementia, a population based study of place of death and associated individual and regional factors, 2001–2010. BMC Neurology, 14, 59. doi: 10.1186/1471-2377-14-59.
StataCorp, Stata Statistical Software (2014). Release 13. College Station, TX, USA: StataCorp LP.
Thompson, S.G. and Barber, J.A. (1999). The distribution of health care costs and their statistical analysis for economic evaluation. Journal of Health Services Research and Policy, 4, 255.
van den Berg, B., Brouwer, W.B. and Koopmanschap, M.A. (2004). Economic valuation of informal care. An overview of methods and applications. European Journal of Health Economics, 5, 36–45.
Warden, V., Hurley, A.C. and Volicer, L. (2003). Development and psychometric evaluation of the Pain Assessment in Advanced Dementia (PAINAD) scale. Journal of the American Medical Directors Association, 4, 9–15.
Weiner, M.F., Martin-Cook, K., Svetlik, D.A., Saine, K., Foster, B. and Fontaine, C.S. (2000). The quality of life in late-stage dementia (QUALID) scale. Journal of the American Medical Directors Association, 1, 114–116.
Wimo, A. and Winblad, B. (2003). Resource utilization in dementia, RUD Lite. Brain Aging, 3, 48–59.
Wolstenholme, J., Fenn, P., Gray, A., Keene, J., Jacoby, R. and Hope, T. (2002). Estimating the relationship between disease progression and cost of care in dementia. British Journal of Psychiatry, 181, 36–42.
Zhu, C.W.et al. (2015). Medicare utilization and expenditures around incident dementia in a multiethnic cohort. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 70, 1448–1453.